Localized scleroderma severity index and global assessments: A pilot study of outcome instruments

Journal of Rheumatology

Volumn 35, Issue 4, 2008, Pages 650-657

  Arkachaisri, Thaschawee ^a   Pino, Sally ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Disease activity; Disease severity; Global assessment; Localized scleroderma; Outcome measure; Skin score

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; INTERRATER RELIABILITY; LOCALIZED SCLERODERMA; MALE; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PHYSICIAN; PILOT STUDY; PRIORITY JOURNAL; RELIABILITY; RHEUMATOLOGY; SCHOOL CHILD; SCORING SYSTEM; SKIN SURFACE; SKINFOLD THICKNESS; VISUAL ANALOG SCALE;

ADOLESCENT; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; SKIN;

EID: 41849130645     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993. J Rheumatol 1997;24:73-80.
2. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am 2002;28:603-24.
3. Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol 1998;20:242-5.
4. Birdi N, Shore A, Rush P, Laxer RM, Silverman ED, Krafchik B. Childhood linear scleroderma: a possible role of thermography for evaluation. J Rheumatol 1992;19:968-73.
5. Hoffmann K, El-Gammal S, Gerbaulet U, Schatz H, Altmeyer P. Examination of circumscribed scleroderma using 20-MHz B-scan ultrasound. In: Altmeyer P, El-Gammal S, Hoffmann K, editors. Ultrasound in dermatology. Berlin, Heidelberg: Springer-Verlag; 1992:231-43.
6. Martini G, Murray KJ, Howell KJ, et al. Juvenile-onset localized scleroderma activity detection by infrared thermography. Rheumatology Oxford 2002;41:1178-82.
7. Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005;85:257-68.
8. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-68.
9. Carmines EG, Zeller RA. Reliability and validity assessment. Thousand Oaks: Sage Publications, Inc.; 1979:17-27.
10. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
11. Beaton DE, Hogg-Johnson S, Bombardier C. Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol 1997;50:79-93.
12. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-25.
13. Liang MH. Evaluating measurement responsiveness. J Rheumatol 1995;22:1191-2.
14. Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28:632-42.
15. Cosnes A, Anglade MC, Revuz J, Radier C. Thirteen-megahertz ultrasound probe: its role in diagnosing localized scleroderma. Br J Dermatol 2003;148:724-9.
16. Seidenari S, Conti A, Pepe P, Giannetti A. Quantitative description of echographic images of morphea plaques as assessed by computerized image analysis on 20 MHz B-scan recordings. Acta Derm Venereol 1995;75:442-5.
17. Serup J. Ten years' experience with high-frequency ultrasound examination of the skin: development and refinement of technique and equipment. In: Altmeyer K, el-Gammal S, Hoffmann K, editors. Ultrasound in dermatology. Berlin, Heidelberg: Springer-Verlag; 1992:41-54.
18. Szymanska E, Nowicki A, Mlosek K, et al. Skin imaging with high frequency ultrasound - preliminary results. Eur J Ultrasound 2000;12:9-16.
19. Charman CR, Venn AJ, Williams HC. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 1999;140:109-11.
20. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:565-70.
21. Tiling-Grosse S, Rees J. Assessment of area of involvement in skin disease: a study using schematic figure outlines. Br J Dermatol 1993;128:69-74.
22. Zulian F, Meneghesso D, Grisan E, et al. A new computerized method for the assessment of skin lesions in localized scleroderma. Rheumatology Oxford 2007;46:856-60.
23. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
24. Lahti A, Kopola H, Harila A, Myllyla R, Hannuksela M. Assessment of skin erythema by eye, laser Doppler flowmeter, spectroradiometer, two-channel erythema meter and Minolta chroma meter. Arch Dermatol Res 1993;285:278-82.
25. Serup J, Agner T. Colorimetric quantification of erythema - a comparison of two colorimeters (Lange Micro Color and Minolta Chroma Meter CR-200) with a clinical scoring scheme and laser-Doppler flowmetry. Clin Exp Dermatol 1990;15:267-72.
26. Albrecht J, Taylor L, Berlin JA, et al. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol 2005;125:889-94.
27. Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 1999;141:185-91.
28. Charman CR, Venn AJ, Williams H. Measuring atopic eczema severity visually, which variables are most important to patients? Arch Dermatol 2005;141:1146-51; discussion 1151.
29. Chuh AA, Chan HH. Effect on quality of life in patients with pityriasis rosea: is it associated with rash severity? Int J Dermatol 2005;44:372-7.
30. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999;79:356-9.
31. Ben-Gashir MA, Hay RJ. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol 2002;147:920-5.
32. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum 1979;22:130-40.
33. Brennan P, Silman A, Black C, et al. Reliability of skin involvement measures in scleroderma. The UK Scleroderma Study Group. Br J Rheumatol 1992;31:457-60.
34. Clements P, Lachenbruch P, Siebold J, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
35. Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-6.
36. Czirjak L, Nagy Z, Aringer M, Riemekasten G, Matucci-Cerinic M, Furst DE. The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 2007;66:966-9.
37. Merkel PA, Clements PJ, Reveille JD, Suarez-Almazor ME, Valentini G, Furst DE. Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. J Rheumatol 2003;30:1630-47.
38. Foeldvari I, Wierk A. Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Rheumatology Oxford 2006;45:76-8.